Dianthus Therapeutics | Attività Correnti



Current Assets Cambiamento Data
Adcock Ingram Holdings ZAR 5.12B 234.71M 2024-12
Alaunos Therapeutics USD 2.76M 795K 2024-12
Avita Medical AUD 57M 15.96M 2024-12
Celltrion KRW 5.37T 121.47B 2024-09
Cspc Pharmaceutical CNY 21.89B 4.58B 2024-12
Dianthus Therapeutics USD 280.9M 6.58M 2024-12
Ecofibre AUD 37.37M 2.03M 2024-06
IQVIA Holdings USD 5.83B 197M 2024-12
Kangmei Pharma CNY 7.01B 15.81M 2024-09
Knight Therapeutics CAD 397.57M 36.96M 2024-09
Laboratorios Farma EUR 489.61M 51.17M 2024-12
Malin Corporation EUR 35.9M 100K 2024-06
Medical Developments International AUD 26.14M 4.89M 2024-06
Moderna USD 6.77B 1.33B 2025-03
Neuren Pharmaceuticals AUD 399.33M 171.29M 2024-12
Organigram Holdings CAD 231.49M 30.73M 2024-12
Organon & Co USD 4.35B 408M 2024-12
Pharma Mar EUR 236.01M 14.24M 2025-03
Qiagen NV USD 1.96B 494.22M 2024-12
Revvity USD 2.32B 31.67M 2025-03
Sartorius EUR 2.16B 45.8M 2025-03
Sino Biopharmaceutical CNY 24.69B 536.67M 2024-12
Tectonic Therapeutic USD 146.86M 15.74M 2024-12
Tilray USD 707.34M 18.54M 2024-11
Viatris USD 9.52B 1.79B 2024-12
Xeris Pharmaceuticals USD 167.66M 4.86M 2024-12
Zz Pientze Pharmaceu 12.18B 849.77M 2025-03



Dianthus Therapeutics Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.